Your browser doesn't support javascript.
loading
Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.
Ding, Yang Y; Stern, Julie W; Jubelirer, Tracey F; Wertheim, Gerald B; Lin, Fumin; Chang, Fengqi; Gu, Zhaohui; Mullighan, Charles G; Li, Yong; Harvey, Richard C; Chen, I-Ming; Willman, Cheryl L; Hunger, Stephen P; Li, Marilyn M; Tasian, Sarah K.
Afiliación
  • Ding YY; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA.
  • Stern JW; University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA.
  • Jubelirer TF; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA.
  • Wertheim GB; University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA.
  • Lin F; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA.
  • Chang F; University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA.
  • Gu Z; University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory, PA, USA.
  • Mullighan CG; Children's Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children's Hospital of Philadelphia, Division of Hematopathology PA, USA.
  • Li Y; Children's Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children's Hospital of Philadelphia, Division of Hematopathology PA, USA.
  • Harvey RC; St Jude Children's Research Hospital, Department of Pathology, Memphis, TN, USA.
  • Chen IM; St Jude Children's Research Hospital, Department of Pathology, Memphis, TN, USA.
  • Willman CL; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA.
  • Hunger SP; University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA.
  • Li MM; University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA.
  • Tasian SK; University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA.
Haematologica ; 103(9): e427-e431, 2018 09.
Article en En | MEDLINE | ID: mdl-29773603
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Proteínas de Fusión Oncogénica / Inhibidores de Proteínas Quinasas / Janus Quinasa 2 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Proteínas de la Matriz de Golgi Tipo de estudio: Diagnostic_studies Límite: Child / Humans / Male Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Proteínas de Fusión Oncogénica / Inhibidores de Proteínas Quinasas / Janus Quinasa 2 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Proteínas de la Matriz de Golgi Tipo de estudio: Diagnostic_studies Límite: Child / Humans / Male Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos